Current Edition


Gilead’s Kite flies higher as Yescarta leads CAR-T therapy class to earlier lymphoma treatment

Existing CAR-T therapies have been saved for blood cancer patients who’ve tried multiple treatments—until now. With a first-in-class nod, the FDA has cleared Yescarta, a …

Continue Reading →

Antares, Lipocine expand testosterone therapy offerings with FDA nod for a new, oral med for hypogonadism

In 2018 with Xyosted, Antares brought to the market a user-friendly testosterone replacement therapy for hypogonadism, with the drug administered at home by weekly injection. …

Continue Reading →

Bayer leads $80M funding round for Cellino, betting on new cell therapy manufacturing platform

Since it was established in 2017, Cellino Biotech has offered an intriguing approach to stem cell therapy manufacturing, combining biology, laser physics, gene editing tools …

Continue Reading →

ASH: Senti Bio’s gene circuit CAR-NK cell therapy enhances cancer killing and safety in leukemia models

Engineered cell therapy has revolutionized the treatment of blood cancers, but precisely selecting the right target to kill off cancer cells while sparing healthy cells …

Continue Reading →

Patient Registries to Bolster Cell- and Gene-Therapy Clinical Trial Data

As the first personalized cell and gene therapies are approved from small clinical trials, researchers propose the creation of publicly accessible databases to pull together …

Continue Reading →

Tianhe Life Sciences leads $9.5m Series A in Clover Biopharma

Tianhe Life Sciences leads $9.5m Series A in Clover Biopharma Clover is utilising its proprietary Trimer-Tag technology platform to develop biologics targeting trimerization-dependent pathways. Clover …

Continue Reading →

CRISPR Therapeutics Announces Planned European Clinical Trial

CRISPR Therapeutics today announced the submission of a Clinical Trial Application (CTA) today for CTX001 in β-thalassemia. CTX001 is an investigational CRISPR gene-edited autologous hematopoietic …

Continue Reading →
lung cancer

AZ teams up with G1 on lung cancer combination therapy

AstraZeneca has signed a deal with US group G1 Therapeutics to test the potential of a new combination therapy for lung cancer. The parties have …

Continue Reading →

New study results support use of DiviTum ® for evaluation of pancreatic cancer

In collaboration with University of Heidelberg, Germany, results from a clinical study of pancreatic cancer are published in the Pancreas scientific journal. The results demonstrate …

Continue Reading →

Imcyse continues patient enrolment in its Phase 1b trial in type 1 diabetes

Imcyse, a biotechnology company developing active specific therapies for the treatment of severe chronic diseases, today announces that it began recruiting patients into its multicenter …

Continue Reading →